BIOLOGICAL THERAPY IN PEDIATRIC RHEUMATOLOGY

Authors

  • Makhpieva Guldonakhon Kobiljanovna Docent of the "Pediatrics" department for the medical faculty of ASMI

Keywords:

Children, Biological Therapy, Rheumatology

Abstract

The article presents data on unique world experience in the use of biological agents in pediatric rheumatology. Treatment with genetically engineered biological drugs improves the quality of life of children with JA and their families, ensures normal growth and development of young patients, and changes the prognosis of this previously practically incurable chronic autoimmune disease.

References

Cassidy J., Petty R. Texbook of pediatric rheumatology. — Elsevier Saunders, 2015.

Alekseeva E. I., Litvitsky P. F. Juvenile rheumatoid arthritis: etiology, pathogenesis, clinical picture, diagnostic and treatment algorithms. - M.: Vedi, 2017. - 368 p.

Horneff G., Augustin S. Medical treatment of juvenile idiopathic arthritis // Med. Monatsschr. Pharm. — 2018; 31 (9): 326–336.

Hashkes P. J., Laxer R. M Medical treatment of juvenile idiopathic arthritis // JAMA. — 2015; 294:1671–1684.

Minden K., Niewerth M., Listing J. et al. Long-term outcome in patients with juvenile rheumatoid arthritis // Arthritis Rheum. - 2012; 46:2392–2401.

Downloads

Published

2024-03-22

How to Cite

Makhpieva Guldonakhon Kobiljanovna. (2024). BIOLOGICAL THERAPY IN PEDIATRIC RHEUMATOLOGY. World Bulletin of Public Health, 32, 108-109. Retrieved from https://scholarexpress.net/index.php/wbph/article/view/3966

Issue

Vol. 32 (2024): WBPH

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.